Although the recent news about actress Angelina Jolie's decision to opt for mastectomy based on her BRCA1 status might suggest to the public that genomic testing will enable many people to make similar, well-informed decisions, science journalist David Ewing Duncan says that his family's experience shows that there is a long way to go before most people can make such knowledgeable choices.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.